Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against fas-induced apoptosis

Arthritis and Rheumatism

Volumn 56, Issue 4, 2007, Pages 1067-1075

  Hayashi, Shinya ^a   Miura, Yasushi ^a   Nishiyama, Takayuki ^a   Mitani, Makoto ^a   Tateishi, Koji ^a   Sakai, Yoshitada ^a   Hashiramoto, Akira ^a   Kurosaka, Masahiro ^a   Shiozawa, Shunichi ^a   Doita, Minoru ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CHIMERIC PROTEIN; DECOY RECEPTOR 3; FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN FC FRAGMENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN LIGHT; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR LIKE MOLECULE 1A; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING COMPETITION; CELL PROTECTION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NICK END LABELING; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; WESTERN BLOTTING;

APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL SURVIVAL; CELLS, CULTURED; DOWN-REGULATION; FAS LIGAND PROTEIN; FIBROBLASTS; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOTOXINS; IN SITU NICK-END LABELING; OSTEOARTHRITIS, KNEE; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE; TRANSFECTION;

EID: 34247270380     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22494     Document Type: Article

References (39)

1. Chou CT, Yang JS, Lee MR. Apoptosis in rheumatoid arthritis - expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. J Pathol 2001;193:110-6.
2. Tak PP, Zvaifler NJ, Green DR, Firestein GS. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 2000;21:78-82.
3. Yamanishi Y, Boyle DL, Rosengren S, Green DR, Zvaifler NJ, Firestein GS. Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A 2002;99:10025-30.
4. Shiozawa S, Shiozawa K, Fujita T. Morphologic observations in the early phase of the cartilage-pannus junction: light and electron microscopic studies of active cellular pannus. Arthritis Rheum 1983;26:472-8.
5. Baier A, Meineckel A, Gay S, Pap T. Apoptosis in rheumatoid arthritis. Curr Opin Rheumatol 2003;15:274-9.
6. Mountz JD, Zhang HG. Regulation of apoptosis of synovial fibroblasts. Curr Dir Autoimmun 2001;3:216-39.
7. Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998;396:699-703.
8. Bai C, Connolly B, Metzker ML, Hilliard CA, Liu X, Sandig V, et al. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci U S A 2000;97:1230-5.
9. Ohshima K, Haraoka S, Sugihara M, Suzumiya J, Kawasaki C, Kanda M, et al. Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas. Cancer Lett 2000;160:89-97.
10. Chen J, Zhang L, Kim S. Quantification and detection of DcR3, a decoy receptor in TNFR family. J Immunol Methods 2004;285: 63-70.
11. Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BS. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 1999; 274:13733-6.
12. Migone TS, Zhang J, Luo X, Zhuang L, Chen C, Hu B, et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002;16:479-92.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Mitani M, Miura Y, Saura R, Kitagawa A, Fukuyama T, Hashiramoto A, et al. Estrogen specifically stimulates expression and production of osteoprotegerin from rheumatoid synovial fibroblasts. Int J Mol Med 2005;15:827-32.
15. Santiago B, Galindo M, Palao G, Pablos JL. Intracellular regulation of Fas-induced apoptosis in human fibroblasts by extracellular factors and cycloheximide. J Immunol 2004;172:560-6.
16. Itoh K, Hase H, Kojima H, Saotome K, Nhishioka K, Kobata T. Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts. Rheumatology (Oxford) 2004;43: 277-85.
17. Strand S, Galle PR. Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications. Mol Med Today 1998;4:63-8.
18. Tsuji S, Hosotani R, Yonehara S, Masui T, Tulachan SS, Nakajima S, et al. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma. Int J Cancer 2003;106:17-25.
19. Firestein GS. Evolving concepts of rheumatoid arthritis (review). Nature 2003;423:356-61.
20. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995;38: 485-91.
21. Hoa TT, Hasunuma T, Aono H, Masuko K, Kobata T, Yamamoto K, et al. Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J Rheumatol 1996;23: 1332-7.
22. Palao G, Santiago G, Galindo M, Paya M, Ramirez JC, Pablos JL. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis (published erratum appears in Arthritis Rheum 2005;52:678). Arthritis Rheum 2004;50:2803-10.
23. Knight MJ, Riffkin CD, Muscat AM, Ashley DM, Hawkins CJ. Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells. Oncogene 2001;20:5789-98.
24. Matsumoto S, Muller-Ladner U, Gay RE, Nishioka K, Gay S. Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol 1996;23: 1345-52.
25. Franz JK, Pap T, Hummel KM, Nawrath M, Aicher WK, Shigeyama Y, et al. Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum 2000;43:599-607.
26. Kitagawa A, Miura Y, Saura R, Mitani M, Ishikawa H, Hashiramoto A, et al. Anchorage on fibronectin via VLA-5 (α5β1 integrin) protects rheumatoid synovial cells from Fas-induced apoptosis. Ann Rheum Dis 2006;65:721-7.
27. Perlman H, Pagliari U, Liu H, Koch AE, Haines GK III, Pope RM. Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1β-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum 2001;44:21-30.
28. Ceponis A, Hietanen J, Tamulaitiene M, Partsch G, Patiala H, Konttinen YT. A comparative quantitative morphometric study of cell apoptosis in synovial membranes in psoriatic, reactive and rheumatoid arthritis. Rheumatology (Oxford) 1999;38:431-40.
29. Kim S, Fotiadu A, Kotoura V. Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia. Clin Immunol 2005;115:286-94.
30. Rosengren S, Firestein GS, Boyle DL. Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 2003;10:1002-10.
31. Ribbens C, Andre B, Kaye O, Kaiser MJ, Bonnet V, Jaspar JM, et al. Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not. Rheumatology (Oxford) 2000;12:1357-65.
32. Tetta C, Camussi G, Modena V, Vittorio CD, Baglioni C. Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. Ann Rheum Dis 1990;49:665-7.
33. Kubota A, Hasegawa K, Suguro T, Koshihara Y. Tumor necrosis factor-α promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts. J Rheumatol 2004;31:426-35.
34. Gravallese EM, Pettit AR, Lee R, Madore R, Manning C, Tsay A, et al. Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor α. Ann Rheum Dis 2003;62:100-7.
35. Youn J, Kim HY, Park JH, Hwang SH, Lee SY, Cho CS, et al. Regulation of TNF-α-mediated hyperplasia through TNF receptors, TRAFs, and NF-κB in synoviocytes obtained from patients with rheumatoid arthritis. Immunol Lett 2002;83:85-93.
36. Deleuran BW, Chu CQ, Field M, Brennan FM, Mitchell T, Feldmann M, et al. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis: implications for local actions of tumor necrosis factor α. Arthritis Rheum 1992;35:1170-8.
37. Hsu TL, Wu YY, Chang YC, Yang CY, Lai MZ, Su WB, et al. Attenuation of Th1 response in decoy receptor 3 transgenic mice. J Immunol 2005;175:5135-45.
38. Doncarli A, Stasiuk LM, Fournier C, Abehsira AO. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis. Eur J Immunol 1997;27:1451-8.
39. Yoshino S. Effect of a monoclonal antibody against interleukin-4 on collagen-induced arthritis in mice. Br J Pharmacol 1998;123: 237-42.